{"transactions":[{"id":4560071,"issuer":{"id":12646,"kind":"organization","name":"TETRALOGIC PHARMACEUTICALS Corp","symbol":"TLOG"},"owners":[{"id":181146,"kind":"organization","name":"NOMURA SECURITIES INTERNATIONAL, INC.","position":1,"cik":"0000072267","reported_name":"NOMURA SECURITIES INTERNATIONAL, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":3147,"kind":"organization","name":"NOMURA HOLDINGS INC","symbol":"NMR","position":2,"cik":"0001163653","reported_name":"NOMURA HOLDINGS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"8% Convertible Notes due 2024","published_at":"2016-11-14T21:43:59.000Z","date":"2016-11-14","kind":"other","acquired":true,"reported_value":3035287,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The conversion rate for the Senior Notes is equal 148.3019 shares of the Company's common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $6.74 per share of common stock), subject to adjustment upon the occurrence of certain specified events."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The conversion rate for the Senior Notes is equal 148.3019 shares of the Company's common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $6.74 per share of common stock), subject to adjustment upon the occurrence of certain specified events."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Remaining Senior Notes are contingently convertible into Common Stock, subject to the Issuer's achievement of certain milestones payments.  The Remaining Senior Notes are not currently convertible.  The Reporting Persons expressly disclaim beneficial ownership of the shares of Common Stock underlying the Remaining Senior Notes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These derivative securities are owned directly by Nomura Securities International, Inc. (\"NSI\"), which is a wholly owned subsidiary of Nomura Holdings, Inc. (\"NH\"), and accordingly NH may be deemed to beneficially own the derivative securities held by NSI."}],"derivative":{"expiration_date":"2024-06-15","underlying":"Common Stock","underlying_shares":450138},"source":{"system":"sec-edgar","filing":"0001104659-16-157087","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/72267/000110465916157087/a4.xml","form_type":"4"}},{"id":4560070,"issuer":{"id":12646,"kind":"organization","name":"TETRALOGIC PHARMACEUTICALS Corp","symbol":"TLOG"},"owners":[{"id":181146,"kind":"organization","name":"NOMURA SECURITIES INTERNATIONAL, INC.","position":1,"cik":"0000072267","reported_name":"NOMURA SECURITIES INTERNATIONAL, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":3147,"kind":"organization","name":"NOMURA HOLDINGS INC","symbol":"NMR","position":2,"cik":"0001163653","reported_name":"NOMURA HOLDINGS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Preferred Stock","published_at":"2016-11-14T21:43:59.000Z","date":"2016-11-14","kind":"other","acquired":true,"shares":892850,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Preferred Stock is initially convertible into one share of Common Stock, subject to adjustment as described in the Certificate of Designations for the Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Preferred Stock is initially convertible into one share of Common Stock, subject to adjustment as described in the Certificate of Designations for the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Preferred Stock is contingently convertible into Common Stock, subject to the Issuer's achievement of certain milestones payments and the deregistration of the Issuer's Common Stock, as further described in the Certificate of Designations for the Preferred Stock.  The Preferred Stock is not currently convertible.  The Reporting Persons expressly disclaim beneficial ownership of the shares of Common Stock underlying the Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock is contingently convertible into Common Stock, subject to the Issuer's achievement of certain milestones payments and the deregistration of the Issuer's Common Stock, as further described in the Certificate of Designations for the Preferred Stock.  The Preferred Stock is not currently convertible.  The Reporting Persons expressly disclaim beneficial ownership of the shares of Common Stock underlying the Preferred Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These derivative securities are owned directly by Nomura Securities International, Inc. (\"NSI\"), which is a wholly owned subsidiary of Nomura Holdings, Inc. (\"NH\"), and accordingly NH may be deemed to beneficially own the derivative securities held by NSI."}],"balance_after":892850,"derivative":{"underlying":"Common Stock","underlying_shares":892850},"source":{"system":"sec-edgar","filing":"0001104659-16-157087","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72267/000110465916157087/a4.xml","form_type":"4"}},{"id":4560069,"issuer":{"id":12646,"kind":"organization","name":"TETRALOGIC PHARMACEUTICALS Corp","symbol":"TLOG"},"owners":[{"id":181146,"kind":"organization","name":"NOMURA SECURITIES INTERNATIONAL, INC.","position":1,"cik":"0000072267","reported_name":"NOMURA SECURITIES INTERNATIONAL, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":3147,"kind":"organization","name":"NOMURA HOLDINGS INC","symbol":"NMR","position":2,"cik":"0001163653","reported_name":"NOMURA HOLDINGS INC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"8% Convertible Notes due 2019","published_at":"2016-11-14T21:43:59.000Z","date":"2016-11-14","kind":"other","acquired":false,"reported_value":3196000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 14, 2016, pursuant to the Exchange Agreement, the Reporting Persons agreed (i) to exchange $160,173 in aggregate principal amount of the Senior Notes for 892,850 shares of Preferred Stock and (ii) to extend the maturity date and modify the conversion terms of the Reporting Persons' remaining $3,035,287 in aggregate principal amount Senior Notes (the \"Remaining Senior Notes\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 14, 2016, pursuant to the Exchange Agreement, the Reporting Persons agreed (i) to exchange $160,173 in aggregate principal amount of the Senior Notes for 892,850 shares of Preferred Stock and (ii) to extend the maturity date and modify the conversion terms of the Reporting Persons' remaining $3,035,287 in aggregate principal amount Senior Notes (the \"Remaining Senior Notes\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 14, 2016, pursuant to the Exchange Agreement, the Reporting Persons agreed (i) to exchange $160,173 in aggregate principal amount of the Senior Notes for 892,850 shares of Preferred Stock and (ii) to extend the maturity date and modify the conversion terms of the Reporting Persons' remaining $3,035,287 in aggregate principal amount Senior Notes (the \"Remaining Senior Notes\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On November 14, 2016, pursuant to the Exchange Agreement, the Reporting Persons agreed (i) to exchange $160,173 in aggregate principal amount of the Senior Notes for 892,850 shares of Preferred Stock and (ii) to extend the maturity date and modify the conversion terms of the Reporting Persons' remaining $3,035,287 in aggregate principal amount Senior Notes (the \"Remaining Senior Notes\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On November 14, 2016, pursuant to the Exchange Agreement, the Reporting Persons agreed (i) to exchange $160,173 in aggregate principal amount of the Senior Notes for 892,850 shares of Preferred Stock and (ii) to extend the maturity date and modify the conversion terms of the Reporting Persons' remaining $3,035,287 in aggregate principal amount Senior Notes (the \"Remaining Senior Notes\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These derivative securities are owned directly by Nomura Securities International, Inc. (\"NSI\"), which is a wholly owned subsidiary of Nomura Holdings, Inc. (\"NH\"), and accordingly NH may be deemed to beneficially own the derivative securities held by NSI."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001104659-16-157087","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72267/000110465916157087/a4.xml","form_type":"4"}}]}